Overexpression and high mutation frequency of p53 protein, which has tumor-promoting signature rather than cell apoptotic activity, were correlated with a poor survival of a broad type of cancers, including GBC,307–309 thus serving as a cancer biomarker. This evidence concerns the gene TP53 and cancer.